News Release
Back to News Releases
UV Flu Technologies Announces Repeat Hospitality Sector Sale and Introduces ABC ROOMS Marketing Initiative
Wednesday, July 28, 2010
|
OTCBB: UVFT
CENTERVILLE, MA -- UV Flu Technologies, Inc. (OTCBB: UVFT) (the "Company") is very pleased to announce that it has received an order to purchase additional units via indoor air quality ("IAQ") specialty distributor Puravair for shipment to the prestigious Seagate Hotel in Delray Beach, Florida (
www.theseagatehotel.com ). This order represents significant customer satisfaction from a very demanding and fastidious customer-oriented property management team.
"The new order for additional units comes just as we are beginning a major marketing cycle directed at the Hotel, Resorts and Casino sector," stated Jack Lennon, President of UV Flu Technologies. "This follow on order is based on full evaluations with actual customers, and the result is a decisive agreement to expand the initiative. The UV-400 air purifier option will be advertised on the hotel website and will be offered at booking. The UV-400 is an FDA listed, airborne bacteria killing unit which can be available in hotel guest rooms on demand, and will also be located in key spa facilities."
Mr. Lennon further announced, "We call our new program ABC ROOMS, which represents guest rooms and public areas treated for Allergens/Bacteria/and Contaminants. A property that provides increased protection against airborne illnesses is offering a significant attractant towards increased and repeat business in this highly competitive sector."
"The Seagate Hotel is very particular regarding options it offers its guests," said Mr. William J. Sander, General Manager of the Seagate. "Our guests want the best, and are very health-conscious. Our entire property is smoke-free, is LEEDS certified as a clean-green property, and we were only the 4th property in North America approved to use Amala organic products in its spa. With this in mind, we've decided to add the UV-400 to our spa, our business and workout facilities, our ABC rooms, as well as our Presidential and Spa suites. "
"As part of our hospitality specific sales efforts we have prepared a presentation that specifically targets the needs of the sector," said UV Flu's Mr. Lennon. "Hotels and casinos have experienced a very difficult business environment over the past two years, and this has led many visionary leaders in the sector to embrace practical and innovative new ways to gain market share at the same time as increasing steady incremental bottom line growth. We project that the first year return on investment will be met with enthusiasm, and it should be noted that healthy guests spend more, gamble more, and are increasingly motivated to become repeat customers."
Further details regarding the Company's business, financial reports and agreements are filed as part of the Company's continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission's ("SEC") EDGAR database.
About UV Flu Technologies, Inc. (OTCBB: UVFT)
UV Flu Technologies is an innovative developer, manufacturer and distributor of bio technology products initially targeting the rapidly growing Indoor Air Quality ("IAQ") industry sector. The Company manufactures the VIRATECH UV-400, which utilizes high-intensity germicidal ultraviolet radiation (UV-C) inside a killing chamber that goes beyond filtration to destroy harmful airborne bacteria at rates exceeding 99.2% on a first-pass basis. The FDA has issued a coveted Class II medical listing that enables UV Flu Technologies to market the product as a medical device.
Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.
ON BEHALF OF THE BOARD
UV Flu Technologies, Inc.
-----------------------------
John J. Lennon, President & CEO
Historical Press Releases
This website contains historical and archived press releases for UV Flu Technologies, Inc. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, UV Flu Technologies, Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.